// App-Quantinova.ai

9101 : Clinical utility of plasma-based digital next-generation sequencing (NGS) in patients with advance-stage lung adenocarcinomas with insufficient tumor samples for tissue genotyping.

Researchers

Presenter

  • Jon Zugazagoitia

Principal Investigators

  • Jose Manuel Trigo Perez

  • Magda Palka

  • Ana Gomez Rueda

  • Eloisa Jantus-Lewintre

  • Carlos Camps

  • Dolores Isla

  • Santiago Ponce Aix

  • Rosario Garcia Campelo

  • Mariano Provencio-Pulla

  • Reyes Bernabe Caro

  • Oscar Juan Vidal

  • Enriqueta Felip

  • Javier De Castro

  • Jose Miguel Sanchez Torres

  • Iris Faull

  • Richard B. Lanman

  • Pilar Garrido Lopez

  • Luis G. Paz-Ares

Medical Centers

  • Medical Oncology Department. Hospital 12 de Octubre, Madrid, Spain

  • Hospital Virgen de la Victoria, Malaga, Spain

  • Medical Oncology Department. Hospital Universitario La Paz, Madrid, Spain

  • Departamento de Biotecnologia, Universitat Politecnica de Valencia, Valencia, Spain

  • Departament de Medicina, Universitat de Valencia, Valencia, Spain

  • Hospital Clinico Universitario Lozano Blesa, Zaragoza, Spain

  • Hospital Doce de Octubre, Madrid, Spain

  • Medical Oncology Service.University Hospital A Coruna (XXIAC-SERGAS), A Coruna, Spain

  • Hospital Puerta de Hierro, Madrid, Spain

  • Hospital Virgen del Rocio, Sevilla, Spain

  • Hospital Universitario La Fe de Valencia, Valencia, Spain

  • Vall d'Hebron University Hospital, Barcelona, Spain

  • Translational Oncology Unit at Medical Oncology Division, Hospital Universitario La Paz, IdipAZ, Madrid, Spain

  • Hospital Universitario de la Princesa, Instituto de Investigacion Sanitaria la Princesa, Madrid, Spain

  • Guardant Health, Rewdwood City, CA

  • Guardant Health, Rewdwood City, CA

  • Hospital Ramon y Cajal, Madrid, Spain

  • University Hospital 12 de October, Madrid, Spain

Locations

  • United States

  • Spain

Companies

  • Guardant Health, Inc

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • Anaplastic lymphoma Kinase

  • Proto-oncogene tyrosine-protein kinase ROS

  • Epidermal growth factor receptor

  • Circulating DNA

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved